Journal profile · Pharmacology, Toxicology and Pharmaceutics-Pharmaceutical Science
Pharmaceutical Fronts
ISSN 2628-5088 · eISSN 2628-5096 · Georg Thieme Verlag KG · Germany
Pharmaceutical Fronts: impact factor 0.8 (journal website); diamond open access (no APC); no APC; review about 15 weeks (community reports); 35 articles in 2025; indexed in Scopus; the journal's website says it has moved to a new publisher.
The journal's website says it has moved to a new publisher: 10.1055/s-00050442 Note: The Arab Journal of Interventional Radiology, the official journal of Pan Arab Interventional Radiology Society (PAIRS), has transferred to a new publisher. Please see the Society website for mo... Source ↗Publisher website ·
Scope
Aims, scope and focus
Pharmaceutical Fronts is published by Georg Thieme Verlag KG. By OpenAlex counts of its recent articles, its largest topics are Innovative Microfluidic and Catalytic Techniques Innovation, Drug Solubulity and Delivery Systems and Chemical Synthesis and Analysis, together about 22.4% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Pharmaceutical Fronts is an international peer-reviewed journal focusing on the rapid and high-quality dissemination of the latest breakthroughs in pharmaceutical development across major scientific and engineering disciplines. It is an affiliated journal of the Chinese Journal of Pharmaceuticals (EI Compendex), which was founded in 1970, and sponsored by Shanghai Institute of Pharmaceutical Industry, Chinese Pharmaceutical Association and China Pharmaceutical Industry Association.The journal is delivering the ultimate reader experience with an innovative manuscript acquisition and review process focusing on information density, utility, and reliability. Its aims to cover original research as well as high quality reviews in medicinal chemistry, process development, and technological innovations for both laboratory and production settings. We will remain agile towards reader feedback and seek to provide a unique service to the global scientific and industrial community in the quest for better medicines and better ways to make them for patients across the world.Publishing 4 times a year in March, June, September, and December, Pharmaceutical Fronts includes significant original research articles as well as high quality reviews, commentaries and short communications in the following areas:Drug & Synthesis TechnologyAsymmetric Catalysis and Green ChemistryMedicinal ChemistryBiopharmaceuticalsPharmaceutical Sciences and Formulation TechnologyAnalytical SciencesEngineering InnovationsProcess Safety and Regulatory Sciences
From the journal's Aims & Scope
Research area (LetPub): Pharmacology, Toxicology and Pharmaceutics-Pharmaceutical Science
Editor-in-chief Girija Prasad RathThePublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Innovative Microfluidic and Catalytic Techniques InnovationEngineering8.2%
- Drug Solubulity and Delivery SystemsPharmacology, Toxicology and Pharmaceutics7.1%
- Chemical Synthesis and AnalysisBiochemistry, Genetics and Molecular Biology7.1%
- Computational Drug Discovery MethodsComputer Science6.6%
- Chemical Synthesis and ReactionsChemistry5.1%
- Synthesis and biological activityChemistry4.1%
- Monoclonal and Polyclonal Antibodies ResearchMedicine4.1%
- Nanoparticle-Based Drug DeliveryMaterials Science3.6%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
ESCICASPublisher website
Other: EBSCO, ProQuest
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 0.8Publisher website ·
- CiteScore 2026-06
- 2.3LetPub ·
- CiteScore (publisher)
- 2.3Publisher website ·
- SJR 2026-06
- 0.29LetPub ·
- SNIP 2026-06
- 0.45LetPub ·
- h-index
- 13OpenAlex ·
- i10-index
- 21OpenAlex ·
- 2-year mean citedness
- 1.2OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 223 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 25 | 25 | 4 |
| 2025 | 35 | 35 | 25 |
| 2024 | 37 | 37 | 87 |
| 2023 | 38 | 38 | 281 |
| 2022 | 32 | 32 | 183 |
| 2021 | 25 | 25 | 91 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 15 weeksLetPub ·
- Submission to publication (journal-reported)
- about 15 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Diamond open access (no APC)DOAJ
Every article is open access and authors pay no article processing charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | No APC | No | CC BY | |
| LetPub | No APC | Yes | — | |
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted4
- commentariesincludes significant original research articles as well as high quality reviews, commentaries and short communicationsLength not stated
- original research articlesincludes significant original research articles as well as high quality reviews, commentaries and short communicationsLength not stated
- reviewsincludes significant original research articles as well as high quality reviews, commentaries and short communicationsLength not stated
- short communicationsincludes significant original research articles as well as high quality reviews, commentaries and short communicationsLength not stated
Policy excerpts from the journal's websiteAuthorship, Peer review
- Authorship
ICMJE recommendations required Model summary
Pharmaceutical Fronts requires that authors follow the ICMJE (International Committee of Medical Journal Editors) recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly work in Medical Journals.
Source ↗Publisher website ·- Peer review
Peer review described in aims and scope text. Model summary
Methods of Information in Medicine publishes international, peer-reviewed, original research articles, reviews, editorials, and letters to the editor.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Georg Thieme Verlag KG
- Country or region
- Germany
- Language
- English
- ISSN
- 2628-5088
- Electronic ISSN
- 2628-5096
- Society / sponsor
- Indian Society of Neuroanaesthesiology and Critical Care
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
FAQ
Frequently asked questions about Pharmaceutical Fronts
What is the impact factor of Pharmaceutical Fronts?
The journal's website gives an impact factor of 0.8; this is the journal's own figure, as LetPub lists none for it; CiteScore 2.3, h-index 13.
How long does peer review take at Pharmaceutical Fronts?
Authors report an average review time of about 15 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Pharmaceutical Fronts?
According to LetPub and DOAJ records, Pharmaceutical Fronts is indexed in Scopus and DOAJ. The journal's website also lists ESCI and CAS; that list has not been checked against each database.
Is Pharmaceutical Fronts open access, and what is the APC?
Pharmaceutical Fronts is a diamond open-access journal (no APC). It charges no article processing charge.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .